Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers.
One of the current challenges in gene therapy is to construct a vector that will target specific tissues. Targeting expression to endothelium is of particular interest in the treatment of several pathologies. We have shown previously that defined regions of the E-selectin and KDR promoters confer endothelial cell specific expression following retroviral delivery. However, the levels of expression were low. In an attempt to increase expression but to preserve the tissue specificity we have exa...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date: